{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:49:21Z","timestamp":1761166161542,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.anndiagpath.2020.151680","type":"journal-article","created":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T06:46:04Z","timestamp":1607841964000},"page":"151680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Could trop-2 overexpression indicate tumor aggressiveness among prostatic adenocarcinomas?"],"prefix":"10.1016","volume":"50","author":[{"given":"\u0130lker","family":"Akarken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yelda","family":"Dere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2020.151680_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.anndiagpath.2020.151680_bb0010","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/ijms20061389","article-title":"Glycans as biomarkers in prostate cancer","volume":"20","author":"Scott","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0015","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1186\/s12885-018-5096-9","article-title":"Expression of FGD4 positively correlates with the aggressive phenotype of prostate cancer","volume":"18","author":"Bossan","year":"2018","journal-title":"BMC Cancer"},{"issue":"20","key":"10.1016\/j.anndiagpath.2020.151680_bb0020","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.3748\/wjg.v11.i20.3051","article-title":"Antitumor effects and radiosensitization of cytosine deaminase and thymidine kinase fusion suicide gene on colorectal carcinoma cells","volume":"11","author":"Wu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0025","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1073\/pnas.78.8.5147","article-title":"Human trophoblast cell-surface antigens defined by monoclonal antibodies","volume":"78","author":"Lipinski","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0030","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ijc.2910620520","article-title":"Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas","volume":"62","author":"Fornaro","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00428-013-1475-4","article-title":"Increased expression of Trop2 correlates with poor survival in extranodal NK\/T cell lymphoma, nasal type","volume":"463","author":"Chen","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0040","first-page":"135","article-title":"CD133, Trop-2 and a2b1 integrin surface receptors as markers of putative human prostate cancer stem cells","volume":"2","author":"Trerotola","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0045","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s00405-018-5045-x","article-title":"The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma","volume":"275","author":"Yang","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151680_bb0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/dvdy.24242","article-title":"Trop2: from development to disease","volume":"244","author":"AR","year":"2015","journal-title":"Dev Dyn"},{"issue":"11","key":"10.1016\/j.anndiagpath.2020.151680_bb0055","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/jcp.24074","article-title":"Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the \u03b21 integrin-RACK1 axis","volume":"227","author":"Trerotola","year":"2012","journal-title":"J Cell Physiol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151680_bb0060","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1158\/0008-5472.CAN-12-3266","article-title":"Trop-2 promotes prostate cancer metastasis by modulating \u03b2(1) integrin functions","volume":"73","author":"Trerotola","year":"2013","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151680_bb0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/onc.2012.36","article-title":"Upregulation of Trop-2 quantitatively stimulates human cancer growth","volume":"32","author":"Trerotola","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0070","first-page":"5325","article-title":"Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors","volume":"62","author":"Calvo","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1476-4598-9-253","article-title":"Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway","volume":"9","author":"Cubas","year":"2010","journal-title":"Mol Cancer"},{"issue":"5","key":"10.1016\/j.anndiagpath.2020.151680_bb0080","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/ijc.28451","article-title":"A novel human Fab antibody for Trop2 inhibits breast cancer growth in vitro and in vivo","volume":"134","author":"Lin","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151680_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6890-12-22","article-title":"Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma","volume":"12","author":"Bignotti","year":"2012","journal-title":"BMC Clin. Pathol."},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151680_bb0090","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1158\/1078-0432.CCR-05-1961","article-title":"Clinical significance of TROP2 expression in colorectal cancer","volume":"12","author":"Ohmachi","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0095","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s10072-013-1326-8","article-title":"TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomas","volume":"34","author":"Ning","year":"2013","journal-title":"Neurol Sci"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0100","article-title":"Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway","volume":"8","author":"Liu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jcp.2008.060590","article-title":"TROP2 expression as prognostic marker for gastric carcinoma","volume":"62","author":"Muhlmann","year":"2009","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151680_bb0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/IJPM.IJPM_202_18","article-title":"The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions","volume":"62","author":"Sadullaho\u011flu","year":"2019","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1477-7819-10-53","article-title":"Significance of EpCAM and TROP2 expression in non-small cell lung cancer","volume":"10","author":"Pak","year":"2012","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/srep33658","article-title":"Impact of TROP2 expression on prognosis in solid tumors: a systematic review and meta-analysis","volume":"6","author":"Zeng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.anndiagpath.2020.151680_bb0125","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2147\/CMAR.S147033","article-title":"Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas","volume":"9","author":"Xu","year":"2017","journal-title":"Cancer Manag. Res."},{"issue":"5","key":"10.1016\/j.anndiagpath.2020.151680_bb0130","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ejca.2009.12.019","article-title":"Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients","volume":"46","author":"Bignotti","year":"2010","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.anndiagpath.2020.151680_bb0135","first-page":"10995","article-title":"Prognostic value of TROP2 in human nasopharyngeal carcinoma","volume":"8","author":"Guan","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151680_bb0140","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.prp.2018.07.017","article-title":"High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma","volume":"214","author":"Tang","year":"2018","journal-title":"Pathol Res Pract"},{"issue":"5","key":"10.1016\/j.anndiagpath.2020.151680_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096993","article-title":"Trop-2 is a determinant of breast cancer survival","volume":"9","author":"Ambrogi","year":"2014","journal-title":"PLos One"},{"issue":"8","key":"10.1016\/j.anndiagpath.2020.151680_bb0150","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00384-009-0725-z","article-title":"Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer","volume":"24","author":"Fang","year":"2009","journal-title":"Int J Colorectal Dis"},{"issue":"17","key":"10.1016\/j.anndiagpath.2020.151680_bb0155","doi-asserted-by":"crossref","first-page":"28725","DOI":"10.18632\/oncotarget.15647","article-title":"Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes","volume":"8","author":"Inamura","year":"2017","journal-title":"Oncotarget"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420302264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420302264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:33:19Z","timestamp":1761078799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420302264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":31,"alternative-id":["S1092913420302264"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151680","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could trop-2 overexpression indicate tumor aggressiveness among prostatic adenocarcinomas?","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151680"}}